• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童镰状细胞病患者的健康相关生活质量:系统评价和荟萃分析。

Health related quality of life in children with sickle cell disease: A systematic review and meta-analysis.

机构信息

Hematology, Oncology, Transplant Program, Alberta Children's Hospital, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.

Hematology, Oncology, Transplant Program, Alberta Children's Hospital, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.

出版信息

Blood Rev. 2022 Nov;56:100982. doi: 10.1016/j.blre.2022.100982. Epub 2022 May 25.

DOI:10.1016/j.blre.2022.100982
PMID:35659429
Abstract

This review had three aims: 1) describe the measures used to assess health-related quality of life (HRQL) in pediatric patients diagnosed with sickle cell disease (SCD); 2) document the biopsychosocial factors related to HRQL in pediatric patients diagnosed with SCD; and 3) complete a meta-analysis comparing HRQL in pediatric patients diagnosed with SCD to healthy controls. Included studies were published in English, quantitatively assessed HRQL as a primary aim, in both SCD and controls, and included participants between 0 and 21 years of age. The final review included 66 articles, with a total of 8642 participants with SCD, 4 months-21 years of age, and 62,458 controls, 5-27 years of age. HRQL was predominately measured using the Pediatric Quality of Life Inventory Generic Core and Sickle Cell Disease Module. Meta-analyses revealed children with SCD had significantly worse HRQL compared to healthy controls (standardized mean difference = -0.93, 95% CI = -1.25, -0.61, p < 0.00001). Worse HRQL was associated with more severe SCD, female sex, and pain. The findings indicate that children with SCD are at risk for worse HRQL compared to their healthy peers and their HRQL may be impacted by several biopsychosocial factors. Future research is needed to examine how sociocultural factors uniquely impact this population and their overall quality of life.

摘要

本综述有三个目的

1)描述用于评估诊断为镰状细胞病(SCD)的儿科患者健康相关生活质量(HRQL)的措施;2)记录与诊断为 SCD 的儿科患者 HRQL 相关的生物心理社会因素;3)完成一项荟萃分析,比较诊断为 SCD 的儿科患者与健康对照组的 HRQL。纳入的研究以英文发表,主要定量评估 HRQL,同时纳入 SCD 和对照组的参与者,年龄在 0 至 21 岁之间。最终综述纳入 66 篇文章,共 8642 名 SCD 患者,年龄为 4 个月至 21 岁,62458 名对照者,年龄为 5 至 27 岁。HRQL 主要使用儿童生活质量问卷通用核心量表和镰状细胞病模块进行测量。荟萃分析显示,与健康对照组相比,SCD 患儿的 HRQL 明显更差(标准化均数差=−0.93,95%置信区间=−1.25,−0.61,p<0.00001)。更差的 HRQL 与更严重的 SCD、女性性别和疼痛有关。研究结果表明,与健康同龄人相比,SCD 患儿的 HRQL 较差,并且他们的 HRQL 可能受到多种生物心理社会因素的影响。未来的研究需要检查社会文化因素如何独特地影响这一人群及其整体生活质量。

相似文献

1
Health related quality of life in children with sickle cell disease: A systematic review and meta-analysis.儿童镰状细胞病患者的健康相关生活质量:系统评价和荟萃分析。
Blood Rev. 2022 Nov;56:100982. doi: 10.1016/j.blre.2022.100982. Epub 2022 May 25.
2
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
3
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
4
Laser therapy for retinopathy in sickle cell disease.激光疗法治疗镰状细胞病视网膜病变。
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.
5
Saline irrigation for allergic rhinitis.用于变应性鼻炎的盐水冲洗
Cochrane Database Syst Rev. 2018 Jun 22;6(6):CD012597. doi: 10.1002/14651858.CD012597.pub2.
6
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.改善镰状细胞病或地中海贫血患者铁螯合疗法依从性的干预措施。
Cochrane Database Syst Rev. 2018 May 8;5(5):CD012349. doi: 10.1002/14651858.CD012349.pub2.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Inhaled nitric oxide for treating pain crises in people with sickle cell disease.吸入一氧化氮治疗镰状细胞病患者的疼痛危象。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD011808. doi: 10.1002/14651858.CD011808.pub3.
9
Music interventions for improving psychological and physical outcomes in people with cancer.音乐干预对改善癌症患者心理和生理结局的影响。
Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD006911. doi: 10.1002/14651858.CD006911.pub4.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

引用本文的文献

1
The moderating effect of family socioeconomic status in the relationship between health-related behaviors and quality of life among the Hakka older adults in Fujian, China.家庭社会经济地位在中国福建客家老年人健康相关行为与生活质量关系中的调节作用。
Qual Life Res. 2025 Apr 16. doi: 10.1007/s11136-025-03973-4.
2
Understanding the role of asthma in acute chest syndrome: a comparative analysis of patients with and without asthma.了解哮喘在急性胸综合征中的作用:哮喘患者与非哮喘患者的对比分析。
Ann Hematol. 2025 Apr;104(4):2179-2187. doi: 10.1007/s00277-025-06233-0. Epub 2025 Mar 5.
3
A road map for uniform, comprehensive long-term follow-up after curative therapy for sickle cell disease.
镰状细胞病根治性治疗后统一、全面长期随访的路线图。
Blood Adv. 2025 Jun 24;9(12):3090-3103. doi: 10.1182/bloodadvances.2024013953.
4
Qualitative Assessment of Health-Related Quality of Life Impacts Associated with Sickle Cell Disease in the United States and United Kingdom.美国和英国与镰状细胞病相关的健康相关生活质量影响的定性评估
Adv Ther. 2025 Feb;42(2):863-885. doi: 10.1007/s12325-024-03038-x. Epub 2024 Dec 16.
5
The Burden of Sickle Cell Disease on Children and Their Caregivers: Caregiver Reports of Children's Health-Related Quality of Life and School Experiences, Caregiver Burden, and Their Association with Frequency of Vaso-Occlusive Crises.镰状细胞病对儿童及其照顾者的负担:照顾者对儿童健康相关生活质量和学校经历、照顾者负担及其与血管闭塞性危象发生频率关联的报告
Patient Relat Outcome Meas. 2023 Nov 28;14:369-381. doi: 10.2147/PROM.S419607. eCollection 2023.
6
A Challenging Case of Severe Sickle Cell Crisis With Multiorgan Involvement: A Case Report.一例伴有多器官受累的严重镰状细胞危象的挑战性病例:病例报告
Cureus. 2023 Jul 25;15(7):e42437. doi: 10.7759/cureus.42437. eCollection 2023 Jul.
7
Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors.Bach1 抑制剂 HPP-D 可介导镰状红细胞祖细胞中 γ-珠蛋白基因的激活。
Blood Cells Mol Dis. 2024 Jan;104:102792. doi: 10.1016/j.bcmd.2023.102792. Epub 2023 Aug 17.